Language :
English
中文
xu deng
Home
Journal Publications
Research Projects
Books
Patents
Teaching
Honors and Awards
Recommended Ph.D.Supervisor
Recommended MA Supervisor
MOBILE Version
Journal Publications
Current position:
Home
>
Journal Publications
[1]Targeting epidermal growth factor receptor signalling pathway: A promising therapeutic option for COVID‐19[J].Reviews in Medical Virology, 2023, 34 (1) : e2500.
[2]Rapid access to icetexane diterpenes: their protective effects against lipopolysaccharides-induced acute lung injury via PI3K/AKT/NF-B axis in macrophages.[J].European Journal of Medicinal Chemistry, 2023, 260: 115769.
[3]Divergent Synthesis of Bis(indolyl) methanes via FeIII catalyzed Regioselective Dehydrogenative Coupling Reactions: A Biomimetic Approach to 6,6’-bis-(debromo)-gelliusine F.[J].Organic & Biomolecular Chemistry, 2023, 21: 639-643.
[4]Development of Strigolactones as Novel Autophagy/Mitophagy Inhibitors against Colorectal Cancer Cells by Blocking the Autophagosome–Lysosome Fusion[J]. America.Journal of Medicinal Chemistry, 2022, 65 (14) : 9706–9717.
[5]Acid-promoted intra-and intermolecular [2+ 2] cycloaddition of indoles with aryl alkynes to access cyclobutene-fused indolines[J]. 英国.Chemical Communications, 2022, 58: 9270-9273.
[6]Efficient Synthesis of Icetexane Diterpenes and Apoptosis Inducing Effect by Upregulating BiP-ATF4-CHOP Axis in Colorectal Cells[J]. USA.Journal of Natural Products, 2021
[7]Modular and scalable synthesis of nematode pheromone ascarosides: implications in eliciting plant defenses[J]. 伦敦.Organic & Biomolecular Chemistry, 2020
[8]Xu Deng, Yingjun Zhou, Yajing Wang, Jinjin Ma, Guangyao Zeng, Lingyang Yan, Jinbao Fan, Wei Cao.Divergent Reactivity in CuII-Catalyzed Oxidative Coupling between Indole/Tryptamine Derivatives and β-Arylacrylic Acids[J].Organic Letters, 2019, 21 (23) : 9506-9511.
[9]Jing, Zhongxian Tian, Jiawei Xu, Qipeng Xie, Yisi Luo, Jiheng Xu, Xu Deng, Maowen Huang, Xiaohui Hua.The inhibitory effect of compound ChlA-F on human bladder cancer cell invasion can be attributed to its blockage of SOX2 protein[J].Cell Death & Differentiation, 2019, 28 (7)
[10]Lung-Wa; Zhang, Hui; Chung, Xiao-Yong; Lv, Yu-Qin; Zhang, Jia-Lin; Guan, Li-Yang; Lan, Xu; Shi, Deng.Enantioselective Rhodium-Catalyzed Cycloisomerization of 1,6-Allenynes to Access 5/6-Fused Bicyclo[4,3,0] Nanodiene[J].Nature Communications, 2019, 10: 949.
[11]Xu-Mu Zhang*, Li Dang*, Hui Lv, Yu-Qing Guan, Zheng-Yu Han, Shao-Fei Ni, Xu Deng.Enantioselective rhodium-catalyzed cycloisomerization of (E)-1,6-enynes[J].Angewandte Chemie International Edition,, 2016, 55: 6295-6299.
[12]Cheng-Feng Xia*, Da-Shan Li, Ming Ding, Xiao-Gang Tong, Kang-Jiang Liang, Xu Deng.Copper-catalyzed radical cyclization to access 3-hydroxypyrroloindoline: biomimetic synthesis of protubonine A[J].Organic Letters, 2014, 16: 3276-3279.
[13]Xu Deng, Yingjun Zhou, Yajing Wang, Chenxi Wang, Jinjin Ma, Guangyao Zeng, Jinbao Fan, Xiaofeng Chen.Access to 3a-Benzoylmethyl Pyrrolidino[2,3-b]indolines via CuII-Catalyzed Radical Annulation/C3-Functionalization Sequence[J].The Journal of Organic Chemistry, 2018, 83 (15) : 8322–8330.
[14]Xu-Mu Zhang, Hui Lv, Ya-Jing Wang, Ning-Ning Huo, Yu-Qing Guan, Xu Deng.An Efficient and Modular Route to C3*-TunePhos-Type Ligands[J].synthesis, 2017: 10.1055/s-0036-15884.
[15]Xu Deng, YingjunZhou, YuanjianLi, Yajing Wang, Guangyao Zeng, Wei Cao, Jinbao Fan, Lan Chen, Jinjin Ma.Dual-targeting Rutaecarpine-NO donor hybrids as novel anti-hypertensive agents by promoting release of CGRP[J]. Elsevier.European Journal of Medicinal Chemistry, 2019, 168 (15) : 146-153.
[16]Qin-Shi Zhao*, Ying Leng*, Li -Yan Peng, Yu Zhao, Juan He, Jing Yang, Yu Shen, Xu Deng.Discovery and Structure-Activity Relationships of ent-Kaurene Diterpenoids as Potent and Selective 11β-HSD1 Inhibitors: Potential Impact in Diabetes[J].European Journal of Medicinal Chemistry, 2013, 65: 403-414.
[17]Xu Deng & Yingjun Zhou, Yajing Wang, Wei Cao, Zhaoquan Wu, Guangyao Zeng.Identification of anti-nociceptive constituents from the pollen of Typha angustifolia L. using effect-directed fractionation[J].Natural Product Research, 2018
[18]Qin-shi Zhao*, Yan Li*, Li-Yan Peng, He, Juan, Yu Zhao, Ling-Mei Kong, Xu Deng.Exploring of drug leads from diversity-oriented Michael-acceptor library derived from natural products[J].Natural products and Bioprospecting, 2012, 2: 210-216.
[19]Qin-Shi Zhao*, Zhu-Jun Yao*, Yan Li, Li-Yan Peng, Yu Zhao, Jia Su, Xu Deng.Development of novel conformation-constrained cytotoxic derivatives of cheliensisin A by embedment of small heterocycles[J].European Journal of Medicinal Chemistry, 2011, 46: 4238-4244.
[20]Y, Mei Dong, Yin-Yin Xie, Yi Jin, Yi-Jie Liu, Run Xiao, Ying Lu, Li-Dong Shao, Xu Deng#, Bai-Xin Ye#.Vibsanin B preferentially targets HSP90?, inhibit interstitial leukocyte migration and ameliorates experimental autoimmue encephalomyelitis[J].Journal of Immunology, 2015, 194: 4489.
total25 1/2
first
previous
next
last
Page